A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L

BACKGROUND: Cisplatin-based chemoradiotherapy is the standard treatment for unresectable, locally advanced non-small-cell lung cancer (NSCLC). This trial evaluated two experimental regimens that combine chemotherapy with concurrent radiotherapy. METHODS: Eligible patients with unresectable stage III...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Tomonari, Seto, Takashi, Yamanaka, Takeharu, Kunitake, Naonobu, Shimizu, Junichi, Kodaira, Takeshi, Nishio, Makoto, Kozuka, Takuyo, Takahashi, Toshiaki, Harada, Hideyuki, Yoshimura, Naruo, Tsutsumi, Shinichi, Kitajima, Hiromoto, Kataoka, Masaaki, Ichinose, Yukito, Nakagawa, Kazuhiko, Nishimura, Yasumasa, Yamamoto, Nobuyuki, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173687/
https://www.ncbi.nlm.nih.gov/pubmed/30206369
http://dx.doi.org/10.1038/s41416-018-0243-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173687/
https://www.ncbi.nlm.nih.gov/pubmed/30206369
http://dx.doi.org/10.1038/s41416-018-0243-2

Ejemplares similares